Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Scientific Industries (SCND) Short-term Investments (2016 - 2023)

Historic Short-term Investments for Scientific Industries (SCND) over the last 13 years, with Q3 2023 value amounting to $809600.0.

  • Scientific Industries' Short-term Investments fell 8472.05% to $809600.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $809600.0, marking a year-over-year decrease of 8472.05%. This contributed to the annual value of $6.4 million for FY2022, which is 7068.85% up from last year.
  • Latest data reveals that Scientific Industries reported Short-term Investments of $809600.0 as of Q3 2023, which was down 8472.05% from $1.8 million recorded in Q2 2023.
  • Scientific Industries' 5-year Short-term Investments high stood at $7.8 million for Q1 2022, and its period low was $301300.0 during Q1 2020.
  • Its 5-year average for Short-term Investments is $3.4 million, with a median of $3.7 million in 2021.
  • As far as peak fluctuations go, Scientific Industries' Short-term Investments soared by 166757.38% in 2021, and later plummeted by 8472.05% in 2023.
  • Scientific Industries' Short-term Investments (Quarter) stood at $345200.0 in 2019, then surged by 1575.78% to $5.8 million in 2020, then rose by 18.82% to $6.9 million in 2021, then tumbled by 37.85% to $4.3 million in 2022, then crashed by 81.05% to $809600.0 in 2023.
  • Its Short-term Investments was $809600.0 in Q3 2023, compared to $1.8 million in Q2 2023 and $3.4 million in Q1 2023.